Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders

References

• Zubin J, Ludwig A M. What is schizophrenia?. Schizophrenia Bulletin 1983; 9: 331–335
   PubMedGoogle Scholar
• Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry 2001; 178: 506–517
   PubMed Web of Science ®Google Scholar
• van Os J, Hanssen M, Bijl R V, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Archives of General Psychiatry 2001; 58: 663–668
   PubMed Web of Science ®Google Scholar
• McGorry P D, Copolov D L, Singh B S. Current concepts in functional psychosis. The case for a loosening of associations. Schizophrenia Research 1990; 3: 221–234
   PubMedGoogle Scholar
• Freimer N, Sabatti C. The human phenome project. Nature Genetics 2003; 34: 15–21
   PubMed Web of Science ®Google Scholar
• Wyatt R J, Alexander R C, Egan M F, Kirch D G. Schizophrenia, just the facts. What do we know, how well do we know it?. Schizophrenia Research 1988; 1: 3–18
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: an Australian study 1997–98: an overview: overview of the methods and results of the study of the low prevalence (psychotic) disorders as part of the National Survey of Mental Health and Wellbeing. Commonwealth of Australia, Canberra 1999
   Google Scholar
• Padmavathi R, Rajkumar S, Srinivasan T N. Schizophrenic patients who were never treated –a study in an Indian urban community. Psychological Medicine 1998; 28: 1113–1117
   PubMed Web of Science ®Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 221–236
   PubMed Web of Science ®Google Scholar
• Miettunen J A, Croudace T, Hayhurst H, Jones P B. Social deprivation, ethnicity and incidence of schizophrenia in Nottingham 1997–1999. Schizophrenia Research 2004; 67(Suppl.1)45
   Google Scholar
• McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2004; 2: 13
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn R S, Selten J-P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry 2003; 60: 565–571
   PubMed Web of Science ®Google Scholar
• SANE. Schizophrenia: costs. An analysis of the burden of schizophrenia and related suicide in Australia. SANE Australia, Melbourne 2002
   Google Scholar
• McGorry P D. Translating advances in schizophrenia treatment: a glass ceiling. Medical Journal of Australia 2003; 178: 425–426
   PubMed Web of Science ®Google Scholar
• Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H. Costeffectiveness of current and optimal treatment for schizophrenia. British Journal of Psychiatry 2003; 183: 427–435
   PubMed Web of Science ®Google Scholar
• Goldberg D. Invited commentary on: cost-effectiveness of current and optimal treatment for schizophrenia. British Journal of Psychiatry 2003; 183: 436
   Google Scholar
• Warner R. How much of the burden of schizophrenia is alleviated by treatment?. British Journal of Psychiatry 2003; 183: 375–376
   PubMedGoogle Scholar
• Tsuang M T, Stone W S, Faraone S V. Towards the prevention of schizophrenia. Biological Psychiatry 2000; 48: 349–356
   PubMedGoogle Scholar
• Green M F. What are the functional consequences of neurocognitive deficits in schizophrenia? [see comment]. American Journal of Psychiatry 1996; 153: 321–330
   PubMed Web of Science ®Google Scholar
• McGlashan T. DSM-IV's version of schizophrenia may be harmful to your health. Schizophrenia Research 2002; 53: 34
   Google Scholar
• Agerbo E, Byrne M, Eaton W W, Mortensen P B. Marital and labor market status in the long run in Schizophrenia. Archives of General Psychiatry 2004; 61: 28–33
   PubMed Web of Science ®Google Scholar
• Yung A R. Invited commentary: the Schizophrenia prodrome: a high risk concept. Schizophrenia Bulletin 2003; 29: 859–865
   PubMed Web of Science ®Google Scholar
• McGorry P D, Yung A R, Phillips L J, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 2002; 59: 921–928
   PubMed Web of Science ®Google Scholar
• McGlashan T H, Zipursky R, Perkins D O, Addington J. Olanzapine for the treatment of the schizophrenia prodrome: 2-year results of a randomised placebo-controlled study. Schizophrenia Research 2004; 67: 164
   Web of Science ®Google Scholar
• Morrison A P, French P, Walford L, et al. A randomised controlled trial of cognitive therapy for the prevention of psychosis in people at ultra-high risk. Schizophrenia Research 2004; 67: 7
   Google Scholar
• Pantelis C, Velakoulis D, McGorry P, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361: 281–288
   PubMed Web of Science ®Google Scholar
• APA. Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington, DC 1994
   Google Scholar
• WHO. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva 1992
   Google Scholar
• McGlashan T H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?. Biological Psychiatry 1999; 46: 899–907
   PubMed Web of Science ®Google Scholar
• Bottlender R, Moeller H-J. The impact of the duration of untreated psychosis on short-and long-term outcome in schizophrenia. Current Opinion in Psychiatry 2003; 16: S39–S43
   Google Scholar
• Lieberman J A. Prediction of outcome in first-episode schizophrenia. Journal of Clinical Psychiatry 1993; 54: 13–17
   PubMed Web of Science ®Google Scholar
• Edwards J, Maude D, McGorry P D, Harrigan S M, Cocks J T. Prolonged recovery in first-episode psychosis. British Journal of Psychiatry Supplement 1998; 172: 107–116
   PubMedGoogle Scholar
• Edwards J, Maude D, Herrmann-Doig T, et al. A service response to prolonged recovery in early psychosis. Psychiatric Services 2002; 53: 1067–1069
   PubMed Web of Science ®Google Scholar
• Robinson D, Woerner M G, Alvir J M.J, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999; 56: 241–247
   PubMed Web of Science ®Google Scholar
• Lieberman J, Jody D, Geisler S, et al. Treatment outcome of first episode schizophrenia. Psychopharmacology Bulletin 1989; 25: 92–96
   PubMedGoogle Scholar
• Lieberman J A, Jody D, Geisler S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry 1993; 50: 369–376
   PubMed Web of Science ®Google Scholar
• Harrigan S M, McGorry P D, Krstev H. Does treatment delay in first-episode psychosis really matter?. Psychological Medicine 2003; 33: 97–110
   PubMed Web of Science ®Google Scholar
• McGorry P D, Jackson H J. The recognition and management of early psychosis: a preventive approach, P D McGorry, H J Jackson. Cambridge University Press, New York 1999
   Google Scholar
• Birchwood M, Fiorillo A. The critical period for early intervention. Psychiatric Rehabilitation Skills 2000; 4: 182–198
   Google Scholar
• McGorry P D, Edwards J, Mihalopolous C, Harrigan S, Jackson H. EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bulletin 1996; 22: 305–326
   PubMed Web of Science ®Google Scholar
• Malla A, Norman R, McLean T, Scholten D, Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Australian and New Zealand Journal of Psychiatry 2003; 37: 407–413
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Jeppesen P, Petersen L, et al. The OPUS trial: a randomised multicentre trial of integrated versus standard treatment for 547 first-episode psychotic patients. Schizophrenia Bulletin 2004; 70(Suppl.)31
   Google Scholar
• Tom K J, Craig TKJ, Garety P, et al. The Lambeth Early Onset (LEO) Team: a randomised controlled trial of assertive outreach for early psychosis. BMJ 2004; 329: 1067
   PubMedGoogle Scholar
• Nordentoft M, Jeppesen P, Abel M, et al. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis: one-year follow-up of a randomised controlled trial. British Journal of Psychiatry 2002; 181: s98–s106
   Web of Science ®Google Scholar
• Bleuler M, Huber G, Gross G, Schuettler R. The long-term course of schizophrenic psychoses: the combined results of two research studies. Der Nervenarzt 1976; 47: 477–481
   PubMedGoogle Scholar
• Harding C M, Zubin J, Strauss J S. Chronicity in schizophrenia: fact, partial fact, or artifact?. Hospital and Community Psychiatry 1987; 38: 477–486
   PubMedGoogle Scholar
• Wallace C, Mullen P E, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of co-morbid substance use disorders. American Journal of Psychiatry 2004; 161: 716–727
   PubMed Web of Science ®Google Scholar
• Mullen P E. A reassessment of the link between mental disorder and violent behaviour, and its implications for clinical practice. Australian and New Zealand Journal of Psychiatry 1997; 31: 3–11
   PubMed Web of Science ®Google Scholar
• Lawrence D M, Holman C D, Jablensky A V, Fuller S A. Suicide rates in psychiatric in-patients: an application of record linkage to mental health research. Australian and New Zealand Journal of Public Health 1999; 23: 468–470
   PubMedGoogle Scholar
• Lawrence D, Jablensky A V, Holman CDJ, Pinder T J. Mortality in Western Australian psychiatric patients. Social Psychiatry and Psychiatric Epidemiology 2000; 35: 341–347
   PubMed Web of Science ®Google Scholar
• Lawrence D, Holman C D, Jablensky A V, Fuller S A, Stoney A J. Increasing rates of suicide in Western Australian psychiatric patients: a record linkage study. Acta Psychiatrica Scandinavica 2001; 104: 443–451
   PubMedGoogle Scholar
• Lawrence D M, Holman C D, Jablensky A V, Hobbs M S. Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. British Journal of Psychiatry 2003; 182: 31–36
   PubMed Web of Science ®Google Scholar
• Aleman A, Kahn R S, Selten J P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry 2003; 60: 565–571
   PubMed Web of Science ®Google Scholar
• Thompson K N, Kulkarni J, Sergejew A A. Extrapyramidal symptoms and oestrogen. Acta Psychiatrica Scandinavica 2000; 101: 130–134
   PubMed Web of Science ®Google Scholar
• Thompson K, Sergejew A, Kulkarni J. Estrogen affects cognition in women with psychosis. Psychiatry Research 2000; 94: 201–209
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Smith D, et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophrenia Research 1996; 20: 247–252
   PubMed Web of Science ®Google Scholar
• Kulkarni J. Women and schizophrenia: a review. Australian and New Zealand Journal of Psychiatry 1997; 31: 46–56
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Riedel A, de Castella A R, et al. Estrogen: a potential treatment for schizophrenia. Schizophrenia Research 2001; 48: 137–144
   PubMed Web of Science ®Google Scholar
• Mortensen P B. Urban–rural differences in the risk for schizophrenia. International Journal of Mental Health 2000; 29: 101–110
   Web of Science ®Google Scholar
• Boyce P, Ellis P, Penrose-Wall J. Introduction to the Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines series. Australian and New Zealand Journal of Psychiatry 2003; 37: 637–640
   PubMed Web of Science ®Google Scholar
• Anonymous. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry Supplement 1997; 154: 1–63
   Google Scholar
• National Health Service. Clinical Standards Board for Scotland: clinical standards for schizophrenia. Clinical Standards Board for Scotland, Edinburgh 2001
   Google Scholar
• National Health Service. Clinical Standards Board for Scotland: evidence base for clinical standards for schizophrenia. Clinical Standards Board for Scotland, Edinburgh 2001
   Google Scholar
• Scottish Intercollegiate Guidelines Network. Psychosocial interventions in the management of schizophrenia. Scottish Intercollegiate Guidelines Network, Edinburgh 1998
   Google Scholar
• National Institute for Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. NICE, London 2002
   Google Scholar
• Canadian Psychiatric Association Canadian clinical practice guidelines for the treatment of schizophrenia. Canadian Journal of Psychiatry Revue Canadienne de Psychiatrie Vo 1998; 43(Suppl. 2)25S–40S
   Google Scholar
• Lambert M, Naber D. Current Schizophrenia. Science Press, London 2004
   Google Scholar
• Yung A R, McGorry P D. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin 1996; 22: 353–370
   PubMed Web of Science ®Google Scholar
• McGorry P D. ‘A stitch in time’… the scope for preventive strategies in early psychosis. The recognition and management of early psychosis: a preventive approach, P D McGorry, H J Jackson. Cambridge Univeristy Press, Cambridge 1999; 3–23
   Google Scholar
• Meadows G, Singh B. Mental health in Australia: collaborative community practice. Oxford University Press, Melbourne 2001
   Google Scholar
• Auditor-General-Victoria. Mental health services for people in crisis. Government of Victoria, Melbourne 2002
   Google Scholar
• Mental Health Council of Australia. Out of hospital, out of mind. Mental Health Council of Australia, Canberra 2003
   Google Scholar
• Mueser K T, Bond G R, Drake R E, Resnick S G. Models of community care for severe mental illness: a review of research on case management. Schizophrenia Bulletin 1998; 24: 37–74
   PubMed Web of Science ®Google Scholar
• Marshall M, Lockwood A. Assertive community treatment for people with severe mental disorders (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Health Department. National service framework for mental health. Her Majesty's Stationary Office, London 1999
   Google Scholar
• Edwards J, McGorry P D. Implementing early intervention in psychosis: a guide to establishing early psychosis services. Martin Dunitz, London 2002
   Google Scholar
• Larsen T K. The transition form the premorbid period to psychosis: how can it be described?. Acta Psychiatrica Scandinavica 2002; 106(Suppl.)10–11
   Google Scholar
• McGorry P D, Killackey E J. Early intervention in psychosis: a new evidence based paradigm. Epidemiologia e Psichiatria Sociale 2002; 11: 237–247
   PubMedGoogle Scholar
• Gournay K, Thornicroft G. A UK perspective of case management. Australian and New Zealand Journal of Psychiatry 2002; 36: 701–702
   PubMedGoogle Scholar
• Rosen A, Teesson M. Does case management work? The evidence and the abuse of evidence-based medicine. Australian and New Zealand Journal of Psychiatry 2001; 35: 731–746
   PubMed Web of Science ®Google Scholar
• Rosen A, Teesson M. A reply to Gournay and Thornicroft. Australian and New Zealand Journal of Psychiatry 2002; 36: 702
   Google Scholar
• Sashidharan S P, Smyth M, Owen A. PRiSM Psychosis Study. Thro'a glass darkly: a distorted appraisal of community care. British Journal of Psychiatry 1999; 175: 504–507
   PubMedGoogle Scholar
• Marshall M, Bond G, Stein L I, et al. PRiSM Psychosis Study. Design limitations, questionable conclusions. British Journal of Psychiatry 1999; 175: 501–503
   PubMed Web of Science ®Google Scholar
• Marshall M, Creed F. Assertive community treatment–is it the future of community care in the UK?. International Review of Psychiatry 2000; 12: 191–196
   Web of Science ®Google Scholar
• Thornicroft G, Becker T, Holloway F, et al. Community mental health teams: evidence or belief?. British Journal of Psychiatry 1999; 175: 508–513
   PubMedGoogle Scholar
• Thornicroft G, Wykes T, Holloway F, Johnson S, Szmukler G. From efficacy to effectiveness in community mental health services: PRiSM Psychosis Study 10. British Journal of Psychiatry 1998; 173: 423–427
   PubMed Web of Science ®Google Scholar
• Csernansky J G, Mahmoud R, Brenner R. Risperidone USASG. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine 2002; 346: 16–22
   PubMed Web of Science ®Google Scholar
• Purdon S E. Cognitive improvement in schizophrenia with novel antipsychotic medications. Schizophrenia Research 1999; 35: s51–s60
   PubMedGoogle Scholar
• Voruganti L, Cortese L, Oyewumi L, Cernovsky Z, Zirul S, Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophrenia Research 2000; 43: 135–145
   PubMed Web of Science ®Google Scholar
• Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. British Medical Journal 2000; 321: 1371–1376
   PubMed Web of Science ®Google Scholar
• Geddes J, Harrison P, Freemantle N, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: author's reply. British Medical Journal 2001; 322: 924
   Google Scholar
• Kapur S, Remington G. Atypical antipsychotics: patients value the lower incidence of extrapyramidial side effects. British Medical Journal 2000; 321: 1360–1361
   PubMedGoogle Scholar
• Rabinowitz J, Bromet E J, Davidson M. Are patients enrolled in first episode psychosis drug trials representative of patients treated in routine clinical practice?. Schizophrenia Research 2003; 61: 149–155
   PubMed Web of Science ®Google Scholar
• Lieberman J A, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. American Journal of Psychiatry 2003; 160: 1396–1404
   PubMed Web of Science ®Google Scholar
• Lieberman J A, Phillips M, Gu H, et al. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 2003; 28: 995–1003
   PubMed Web of Science ®Google Scholar
• Davis J, Chen N, Glick I. A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry 2003; 60: 553–564
   PubMed Web of Science ®Google Scholar
• Geddes J. Generating evidence to inform policy and practice: the example of the second generation ‘atypical’ antipsychotics. Schizophrenia Bulletin 2004; 29: 105–114
   Google Scholar
• Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics; a systematic review and meta-analysis. Lancet 2003; 361: 1581–1589
   PubMed Web of Science ®Google Scholar
• Marder S R, Essock S M, Miller A L, et al. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 2004; 161: 1334–1349
   PubMed Web of Science ®Google Scholar
• Fromm-Reichmann F. Principles of intensive psychotherapy. Chicago University Press, Chicago 1950
   Google Scholar
• Mueser K, Bond G R. Psychosocial treatment approaches for schizophrenia. Current Opinion in Psychiatry 2000; 13: 27–35
   Web of Science ®Google Scholar
• Mojtabai R, Nicholson R A, Carpenter B N. Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies. Schizophrenia Bulletin 1998; 24: 569–587
   PubMed Web of Science ®Google Scholar
• Huxley N A, Rendall M, Sederer L. Psychosocial treatments in schizophrenia: a review of the past 20 years. Journal of Nervous and Mental Disease 2000; 188: 187–201
   PubMed Web of Science ®Google Scholar
• Lauriello J, Bustillo J, Keith S J. A critical review of research on psychosocial treatment of schizophrenia. Biological Psychiatry 1999; 46: 1409–1417
   PubMed Web of Science ®Google Scholar
• Bustillo J R, Lauriello J, Horan W P, Keith S J. The psychosocial treatment of schizophrenia: an update. American Journal of Psychiatry 2001; 158: 163–175
   PubMed Web of Science ®Google Scholar
• Barrowclough C, Tarrier N, Lewis S, et al. Randomised controlled effectiveness trial of a needs-based psychosocial intervention service for carers of people with schizophrenia. British Journal of Psychiatry 1999; 174: 505–511
   PubMed Web of Science ®Google Scholar
• Pharoah F, Rathbone J, Mari J, Streiner D. Family interventions for schizophrenia (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• de Jesus Mari J, Streiner D L. An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychological Medicine 1994; 24: 565–578
   PubMed Web of Science ®Google Scholar
• Pitschel-Walz G, Leucht S, Baeuml J, Kissling W, Engel R R. The effect of family interventions on relapse and rehospitalization in schizophrenia –a meta-analysis. Schizophrenia Bulletin 2001; 27: 73–92
   PubMed Web of Science ®Google Scholar
• Dixon L B, Lehman A F. Family interventions for schizophrenia. Schizophrenia Bulletin 1995; 21: 631–643
   PubMed Web of Science ®Google Scholar
• McFarlane W R. Families, patients and clinicians as partners clinical strategies and research outcomes in single- and multiple-family psychoeducation. Helping families cope with mental illness. Chronic mental illness, H P Lefley, M Wasow. Harwood Academic Publishers, ChurSwitzerland 1994; 2: 195–222
   Google Scholar
• McFarlane W R. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Family interventions in mental illness. New directions for mental health services, No. 62, A B Hatfield. Jossey Bass, San Francisco 1994; 13–22
   Google Scholar
• McFarlane W R, Lukens E, Link B, et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Archives of General Psychiatry 1995; 52: 679–687
   PubMed Web of Science ®Google Scholar
• McFarlane W R, Link B, Dushay R, et al. Psychoeducational multiple family groups: four-year relapse outcome in schizophrenia. Family Process 1995; 34: 127–144
   PubMed Web of Science ®Google Scholar
• McFarlane W R. Multifamily groups in the treatment of severe psychiatric disorders. Guilford Press, New York 2002
   Google Scholar
• McFarlane W R, Dixon L, Lukens E, Lucksted A. Family psychoeducation and schizophrenia: a review of the literature. Journal of Marital and Family Therapy 2003; 29: 223–245
   PubMed Web of Science ®Google Scholar
• Jorm A, Korten A, Jacomb P, Christensen H, Rodgers B, Pollitt P. ‘Mental health literacy’: a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Medical Journal of Australia 1997; 166: 182–186
   PubMed Web of Science ®Google Scholar
• Pekkala E, Merinder L. Psychoeducation for schizophrenia. The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Cormac I, Jones C, Campbell C, Silvera da Mota Neto J. Cognitive behaviour therapy for schizophrenia. The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Turkington D, Kingdon D, Turner T. for the Insight into Schizophrenia Research G. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry 2002; 180: 523–527
   PubMed Web of Science ®Google Scholar
• Green M F. Cognitive remediation in schizophrenia: is it time yet?. American Journal of Psychiatry 1993; 150: 178–187
   PubMed Web of Science ®Google Scholar
• Hayes R L, McGrath J J. Cognitive rehabilitation for people with schizophrenia and related conditions (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Tarrier N, Yusupoff L, Kinney C, et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. British Medical Journal 1998; 317: 303–307
   PubMed Web of Science ®Google Scholar
• Sensky T, Turkington D, Kingdon D, et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry 2000; 57: 165–172
   PubMed Web of Science ®Google Scholar
• Drury V, Birchwood M, Cochrane R, Macmillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. British Journal of Psychiatry 1996; 169: 602–607
   PubMed Web of Science ®Google Scholar
• Drury V, Birchwood M, Cochrane R, Macmillan F. Cognitive therapy and recovery from acute psychosis: a controlled trial I. Impact on psychotic symptoms. British Journal of Psychiatry 1996; 169: 593–601
   PubMed Web of Science ®Google Scholar
• Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia. I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 32: 763–782
   PubMed Web of Science ®Google Scholar
• Corrigan P W, Green M F, Toomey R. Cognitive correlates to social cue perception in schizophrenia. Psychiatry Research 1994; 53: 141–151
   PubMed Web of Science ®Google Scholar
• Kopelowicz A, Liberman R P, Zarate R. Psychosocial treatments for schizophrenia. A guide to treatments that work, 2nd edn., P E Nathan, J M Gorman. Oxford University Press, London 2002; 201–228
   Google Scholar
• Penn D L, Mueser K T. Research update on the psychosocial treatment of schizophrenia. American Journal of Psychiatry 1996; 153: 607–617
   PubMed Web of Science ®Google Scholar
• Robertson L, Connaughton J, Nicol M. Life skills programmes for chronic mental illnesses (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Velligan D I, Prihoda T J, Ritch J L, Maples N, Bow-Thomas C C, Dassori A. A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients. Schizophrenia Bulletin 2002; 28: 283–292
   PubMed Web of Science ®Google Scholar
• Velligan D I, Bow-Thomas C C, Huntzinger C, et al. Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. American Journal of Psychiatry 2000; 157: 1317–1323
   PubMed Web of Science ®Google Scholar
• Velligan D I, Bow-Thomas C C, Mahurin R K, Miller A L, Halgunseth L C. Do specific neurocognitive deficits predict specific domains of community function in schizophrenia?. Journal of Nervous and Mental Disease 2000; 188: 518–524
   PubMed Web of Science ®Google Scholar
• Velligan D I, Bow-Thomas C C. Two case studies of cognitive adaptation training for outpatients with schizophrenia. Psychiatric Services 2000; 51: 25–29
   PubMed Web of Science ®Google Scholar
• Green M F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996; 153: 321–330
   PubMed Web of Science ®Google Scholar
• Crowther R, Marshall M, Bond G R, Huxley P. Vocational rehabilitation for people with severe mental illness (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Jablensky A, McGrath J, Herrman H, et al. People living with psychotic illness: an Australian Study 1997–98. National Mental Health and Wellbeing Report 4. Commonwealth Department of Health and Aged Care, Canberra 1999
   Google Scholar
• Fuller T R, Oka M, Otsuka K, Yokoyama N, Liberman R P, Niwa S I. Rehab rounds: a hybrid supported employment program for persons with schizophrenia in Japan [In Process Citation]. Psychiatric Services 2000; 51: 864–866
   PubMedGoogle Scholar
• Mueser K T, Becker D R, Torrey W C, et al. Work and nonvocational domains of functioning in persons with severe mental illness: a longitudinal analysis. Journal of Nervous and Mental Disease 1997; 185: 419–426
   PubMed Web of Science ®Google Scholar
• Bond G R, Resnick S G, Drake R E, Xie H, McHugo G J, Bebout R R. Does competitive employment improve nonvocational outcomes for people with severe mental illness?. Journal of Consulting and Clinical Psychology 2001; 69: 489–501
   PubMed Web of Science ®Google Scholar
• Torrey W C, Mueser K T, McHugo G H, Drake R E. Self-esteem as an outcome measure in studies of vocational rehabilitation for adults with severe mental illness. Psychiatric Services 2000; 51: 229–233
   PubMed Web of Science ®Google Scholar
• Drake R E, Becker D R, Bond G R. Recent research on vocational rehabilitation for persons with severe mental illness. Current Opinion in Psychiatry 2003; 16: 451–455
   Google Scholar
• Drake R E, Becker D R, Clark R E, Mueser K T. Research on the individual placement and support model of supported employment. Psychiatric Quarterly 1999; 70: 289–301
   PubMed Web of Science ®Google Scholar
• Drake R E, McHugo G J, Bebout R R, et al. A randomized clinical trial of supported employment for inner-city patients with severe mental disorders. Archives of General Psychiatry 1999; 56: 627–633
   PubMed Web of Science ®Google Scholar
• Bond G R, Drake R E, Mueser K T, Becker D R. An update of supported employment for people with severe mental illness. Psychiatric Services 1997; 48: 335–346
   PubMed Web of Science ®Google Scholar
• Drake R E, Becker D R, Biesanz J C, Wyzik P F, Torrey W C. Day treatment versus supported employment for persons with severe mental illness: a replication study. Psychiatric Services 1996; 47: 1125–1127
   PubMed Web of Science ®Google Scholar
• Marshall M, Gray A, Lockwood A, Green R. Case management for people with severe mental disorders (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Marshall M, Lockwood A. The effectiveness of case management and assertive community treatment for people with severe mental disorders. The treatment of schizophrenia –status and emerging trends, H D Brenner, W Boeker, R Genner. Hogrefe & Huber, Kirkland, WA 2001; 181–194
   Google Scholar
• Thornicroft G, Wykes T, Holloway F, Johnson S, Szmukler G. From efficacy to effectiveness in community mental health services. PRiSM Psychosis Study. British Journal of Psychiatry 1998; 173: 423–427
   PubMed Web of Science ®Google Scholar
• Marshall M, Bond G, Stein L I, et al. Test MA. PRiSM Psychosis Study. Design limitations, questionable conclusions. British Journal of Psychiatry 1999; 175: 501–503
   PubMed Web of Science ®Google Scholar
• Burns T, Creed F, Fahy T, Thompson S, Tyrer P, White I. Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet 1999; 353: 2185–2189
   PubMed Web of Science ®Google Scholar
• Burns T, Lloyd H. Is a team approach based on staff meetings cost-effective in the delivery of mental health care?. Current Opinion in Psychiatry 2004; 17: 311–314
   Web of Science ®Google Scholar
• Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy: 18-month follow-up. British Journal of Psychiatry 1998; 172: 413–419
   PubMed Web of Science ®Google Scholar
• Hayward P, Kemp R, David A. Compliance therapy a collaborative approach to psychiatric medication. Psychosis: Psychological approaches and their effectiveness, B Martindale, A Bateman, M Crowe, F Marginson. Gaskell, London 2000; 50–67
   Google Scholar
• Sullivan H S. The onset of schizophrenia. American Journal of Psychiatry 1927; 7: 105–134
   Google Scholar
• Arieti S. An overview of schizophrenia from a predominantly psychological approach. American Journal of Psychiatry 1974; 131: 241–249
   PubMed Web of Science ®Google Scholar
• McGorry P D. An overview of the background and scope for psychological interventions in early psychosis. Psychological interventions in early psychosis: a treatment handbook, J Gleeson, P D McGorry. Wiley, Chichester 2004; 1–21
   Google Scholar
• Gleeson J, Larsen T K, McGorry P. Psychological treatment in pre- and early psychosis. Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 2003; 31: 229–245
   PubMedGoogle Scholar
• Malmberg L, Fenton M. Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness (Cochrane Review). The Cochrane Library. Wiley, Chichester 2004, Issue 1
   Google Scholar
• Harrison G, Glazebrook C, Brewin J, et al. Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom. Psychological Medicine 1997; 27: 799–806
   PubMed Web of Science ®Google Scholar
• Schaffner K F, McGorry P D. Preventing severe mental illnesses –new prospects and ethical challenges. Schizophrenia Research 2001; 51: 3–15
   PubMed Web of Science ®Google Scholar
• McGorry P D, Yung A R, Phillips L J. ‘Closing in’: what features predict the onset of first-episode psychosis within an ultra-high-risk group?. The early stages of schizophrenia, R B Zipursky, S C Schulz. American Psychiatric Publishing, Washington, DC 2002; 3–31
   Google Scholar
• Woods S W, Brier A, Zipursky R B, et al. Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry 2003; 54: 453–464
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Early detection and intervention in the initial prodromal phase of Schizophrenia. Pharmacopsychiatry 2003; 36: S162–S167
   PubMed Web of Science ®Google Scholar
• Zipursky R, Schulz C. The early stages of schizophrenia. American Psychiatric Publishing, Washington, DC 2002
   Google Scholar
• Norman RMG, Malla A K. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine 2001; 31: 381–400
   PubMed Web of Science ®Google Scholar
• Malla A K. Norman RMG. Early intervention in schizophrenia and related disorders: advantages and pitfalls. Current Opinion in Psychiatry 2002; 15: 17–23
   Web of Science ®Google Scholar
• Ho B-C, Alicata D, Ward J, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. American Journal of Psychiatry 2003; 160: 142–148
   PubMedGoogle Scholar
• Larsen T K, McGlashan T H, Johannessen J O, et al. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. American Journal of Psychiatry 2001; 158: 1917–1919
   PubMed Web of Science ®Google Scholar
• Johannessen J O, McGlashan T H, Larsen T K, et al. Mental health literacy, help seeking and access to treatment in early psychosis. Acta Psychiatrica Scandinavica 2002; 106(S413)9
   PubMedGoogle Scholar
• Melle I, Larsen T K, Haahr U, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Archives of General Psychiatry 2004; 61: 143–150
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, Kulkarni J. Home-oriented management programme for people with early psychosis. British Journal of Psychiatry 1998; 172(Suppl. 33)39–44
   Web of Science ®Google Scholar
• McGorry P D, Chanen A, McCarthy E, Van Riel R, McKenzie D, Singh B S. Posttraumatic stress disorder following recent-onset psychosis. An unrecognized postpsychotic syndrome. Journal of Nervous and Mental Disease 1991; 179: 253–258
   PubMed Web of Science ®Google Scholar
• Meyer H, Taiminen T, Vuori T, Aeijaelae A, Helenius H. Posttraumatic stress disorder symptoms related to psychosis and acute involuntary hospitalization in schizophrenic and delusional patients. Journal of Nervous and Mental Disease 1999; 187: 343–352
   PubMed Web of Science ®Google Scholar
• Shaw K, McFarlane A, Bookless C. The phenomenology of traumatic reactions to psychotic illness. Journal of Nervous and Mental Disease 1997; 185: 434–441
   PubMed Web of Science ®Google Scholar
• Lelliott P, Quirk A. What is life like on acute psychiatric wards?. Current Opinion in Psychiatry 2004; 17: 297–301
   Web of Science ®Google Scholar
• Emsley R A. Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group. Schizophrenia Bulletin 1999; 25: 721–729
   PubMed Web of Science ®Google Scholar
• Merlo M C.G, Hofer H. Systemic considerations for the inpatient treatment of first-episode, acutely psychotic patients. Cognitive therapy with schizophrenic patients: the evolution of a new treatment approach, M C.G Merlo, C Perris, H D Brenner. Hogrefe & Huber, Kirkland, WA 2002; 68–73
   Google Scholar
• Remington G J, Bezchlibnyk-Butler K. Current concepts in the pharmacotherapy of acute psychosis. CNS Drugs 1998; 9: 191–202
   Web of Science ®Google Scholar
• American Diabetes Association. American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Diabetes Care 2004; 27: 596–601, Consensus development conference on antipsychotic drugs and obesity and diabetes
   PubMed Web of Science ®Google Scholar
• Jackson H, McGorry P, Edwards J, et al. Cognitively-oriented psychotherapy for early psychosis (COPE). Preliminary results. British Journal of Psychiatry Supplement 1998; 172: 93–100
   PubMedGoogle Scholar
• Meltzer H Y, Alphs L, Green A I, et al. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Archives of General Psychiatry 2003; 60: 82–91
   PubMed Web of Science ®Google Scholar
• Ho B C, Andreasen N C. Long delays in seeking treatment for schizophrenia. Lancet 2001; 357: 898–900
   PubMed Web of Science ®Google Scholar
• Power P J.R, Bell R J, Mills R, et al. Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Australian and New Zealand Journal of Psychiatry 2003; 37: 414–420
   PubMed Web of Science ®Google Scholar
• Linszen D H, Dingemans P M, Nugter M A, Van der Does A J.W, Scholte W F, Lenior M A. Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophrenia Bulletin 1997; 23: 119–130
   PubMed Web of Science ®Google Scholar
• Lenior M E, Dingemans P M.A.J, Schene A H, Hart A A.M, Linszen D H. The course of parental expressed emotion and psychotic episodes after family intervention in recent-onset schizophrenia. A longitudinal study. Schizophrenia Research 2002; 57: 183–190
   PubMedGoogle Scholar
• Power P. Suicide and early psychosis. The recognition and management of early psychosis: a preventive approach, P D McGorry, H J Jackson. Cambridge University Press, New York 1999; 338–362
   Google Scholar
• Bond G R, Drake R E, Becker D R, Mueser K T. Effectiveness of psychiatric rehabilitation approaches for employment of people with severe mental illness. Journal of Disability Policy Studies 1999; 10: 18–52
   Google Scholar
• Bond G R, Becker D R, Drake R E, et al. Implementing supported employment as an evidence-based practice. Psychiatric Services 2001; 52: 313–322
   PubMed Web of Science ®Google Scholar
• Dixon L, Hoch J S, Clark R, et al. Cost-effectiveness of two vocational rehabilitation programs for persons with severe mental illness. Psychiatric Services 2002; 53: 1118–1124
   PubMed Web of Science ®Google Scholar
• McHugo G J, Drake R E, Becker D R. The durability of supported employment effects. Psychiatric Rehabilitation Journal 1998; 22: 55–61
   Web of Science ®Google Scholar
• Mihalopoulos C, McGorry P D, Carter R C. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica 1999; 100: 47–55
   PubMed Web of Science ®Google Scholar
• Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia. II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychological Medicine 2002; 32: 783–791
   PubMed Web of Science ®Google Scholar
• Barrowclough C, Haddock G, Tarrier N, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry 2001; 158: 1706–1713
   PubMed Web of Science ®Google Scholar
• Jablensky A, Lawrence D. Schizophrenia and cancer: is there a need to invoke a protective gene?. Archives of General Psychiatry 2001; 58: 579–580
   PubMed Web of Science ®Google Scholar
• Pantelis C, Lambert T J. Managing patients with ‘treatment-resistant’ schizophrenia. Medical Journal of Australia 2003; 5: S62–S66
   Google Scholar